Alida Biosciences raised $7.5M in a Series A funding led by Genoa Ventures and Early Access Launch of Innovative Products for Epitranscriptomic Research
Amount Raised
$7.5 Million
Round Type
Series A
San DiegoBiotechnologyInvestors
Description
Alida Biosciences has successfully completed a $7.5 million Series A funding round led by Genoa Ventures, with participation from FusionX Ventures and Vertical Venture Partners. The funding is complemented by two ongoing SBIR grants totaling $4 million from The National Human Genome Research Institute (NHGRI). In addition, AlidaBio has unveiled the Early Access launch of two products: the EpiPlex™ RNA Library Prep Kit and the EpiScout™ Analysis Suite.
Quick answer
Alida Biosciences Inc. raised $7.5 Million in a Series A round, dated June 12, 2024. Investors: Vertical Venture Partners, Fusion X Ventures and Genoa Ventures. Alida Biosciences Inc. is based in San Diego, California, United States.
- How much did Alida Biosciences Inc. raise?
- Alida Biosciences Inc. raised $7.5 Million in a Series A round on June 12, 2024.
- Who invested in Alida Biosciences Inc?
- Vertical Venture Partners, Fusion X Ventures and Genoa Ventures are named as investors in this round.
- What does Alida Biosciences Inc. do?
- Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
- Where is Alida Biosciences Inc. based and how big is it?
- Alida Biosciences Inc. is based in San Diego, California, United States. Fundz records about 19 employees.
- Who are the decision-makers at Alida Biosciences Inc?
- Fundz holds 3 contacts at Alida Biosciences Inc., including the Senior Global Sales Manager. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Alida Biosciences Inc. that raised within 45 days of this round, from Fundz verified event records.
- Axe Compute Inc. raised $2.2M on July 26, 2024.
- Revi R Therapeutics raised $30M (Series A) on July 26, 2024.
- Amporin Pharmaceuticals raised $170K (Grant) on July 26, 2024.
- Confo Therapeutics raised $65M (Series B) on July 26, 2024.
- 4D Medicine raised $4.4M (Series A) on July 26, 2024.
- Endolytix Technology raised $5M on July 26, 2024.
Who to call at Alida Biosciences Inc., and when
A new round usually means Alida Biosciences Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alida Biosciences Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alida Biosciences Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alida Biosciences Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alida Biosciences Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAlida Biosciences Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.